Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Prairie Du Sac › NPI 1861466153
Hospital

Sauk Prairie Healthcare INC

Sauk Prairie Healthcare INC was paid $2.79M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 13% of everything it billed.

33Billing provider infoSAUK PRAIRIE HEALTHCARE INC
PRAIRIE DU SAC, WI 53578
33aNPI1861466153assigned 02/14/2006
28Total paid$2.79M
24GClaims125,572
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Wisconsin

Rank by total paid#32 of 60
Median peer was paid$2.90M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201813,329$309K
201913,091$309K
202013,107$299K
202121,061$415K
202221,437$460K
202325,341$525K
2024incomplete18,206$472K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 13% 5,448 4,824 $363K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 5,760 5,167 $323K
96361 Intravenous infusion, hydration; each additional hour 11% 2,850 2,181 $301K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.1% 3,940 3,465 $199K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 5.8% 3,673 3,146 $161K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5.6% 2,578 2,265 $155K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5.5% 3,273 2,887 $155K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 5.1% 2,248 1,777 $143K
80053 Comprehensive metabolic panel 4.4% 5,778 4,710 $122K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3.1% 924 797 $85K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.9% 1,864 1,591 $81K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.1% 1,351 1,219 $60K
93 more codes
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.0% 1,398 $56K
80048 Basic metabolic panel (calcium, ionized) 1.6% 2,027 $44K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 6,296 $34K
81001 1.2% 3,510 $34K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 480 $33K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 558 $32K
99214 Doctor's office visit, returning patient (more involved) <1% 495 $27K
70450 Computed tomography, head or brain; without contrast material <1% 473 $26K
84703 <1% 2,450 $25K
87081 <1% 762 $25K
87088 <1% 3,419 $24K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 671 $22K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 796 $19K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 175 $17K
99203 Doctor's office visit, new patient (routine) <1% 264 $15K
82962 <1% 1,447 $15K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 889 $15K
81003 <1% 1,923 $15K
84484 <1% 1,851 $14K
83605 <1% 1,176 $10K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,508 $9K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 64 $9K
82948 <1% 511 $9K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,401 $8K
83690 <1% 1,652 $8K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 205 $8K
85027 <1% 1,585 $7K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 89 $7K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 105 $6K
87186 <1% 808 $5K
71046 Radiologic examination, chest; 2 views <1% 1,722 $4K
84443 Thyroid stimulating hormone (TSH) <1% 383 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $4K
87077 <1% 787 $4K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 78 $4K
83735 <1% 955 $4K
80306 <1% 249 $3K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 43 $3K
85610 <1% 752 $3K
73610 <1% 559 $2K
99204 Doctor's office visit, new patient (more involved) <1% 55 $2K
88720 <1% 26 $2K
85379 <1% 364 $2K
84145 <1% 118 $2K
73630 <1% 320 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,020 $1K
83880 <1% 62 $1K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,993 $1K
0012A <1% 53 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,296 $1K
76830 Ultrasound, transvaginal <1% 26 $989.44
0011A <1% 52 $956.82
83036 Hemoglobin; glycosylated (A1C) <1% 152 $841.75
71045 Radiologic examination, chest; single view <1% 1,124 $840.78
77067 Screening mammography, bilateral, including computer-aided detection <1% 95 $780.41
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 58 $778.98
36415 Collection of venous blood by venipuncture <1% 5,787 $687.61
77063 Screening digital breast tomosynthesis, bilateral <1% 43 $671.76
86140 <1% 67 $473.83
85730 <1% 109 $397.44
80320 <1% 155 $380.71
96375 Therapeutic injection; each additional sequential IV push <1% 2,264 $340.05
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 73 $324.82
G0381 Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 13 $259.73
0064A <1% 23 $180.48
29799 <1% 16 $127.32
73502 <1% 80 $125.94
80061 Lipid panel <1% 13 $95.08
97161 <1% 12 $82.33
73030 <1% 39 $65.24
87210 <1% 15 $48.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,290 $22.64
J2704 Injection, propofol, 10 mg <1% 2,022 $8.24
J7030 Infusion, normal saline solution , 1000 cc <1% 4,195 $5.33
J0690 Injection, cefazolin sodium, 500 mg <1% 404 $4.59
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,015 $3.65
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,714 $1.97
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,666 $1.57
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,347 $1.11
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,115 $0.37
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,418 $0.36
J1170 Injection, hydromorphone, up to 4 mg 0% 864 $0.00
A9270 Non-covered item or service 0% 390 $0.00
73560 0% 30 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 24 $0.00
96376 0% 47 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 14 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 0% 14 $0.00
J7699 Noc drugs, inhalation solution administered through dme 0% 12 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 200 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 26 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 14 $0.00
73562 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDREGNEY, JAMES (CFO)
Same official

Other billing entities under DREGNEY, JAMES

Full network →
ProviderLocationPaid
Sauk Prairie Healthcare, INC.Sauk City, WI$260K
Sauk Prairie Healthcare INCPrairie Du Sac, WI$154K
Sauk Prairie Healthcare INCSpring Green, WI$32K
Sauk Prairie Healthcare INCLodi, WI$23K
Sauk Prairie Healthcare INCPlain, WI$6K
Sauk Prairie Healthcare INCMazomanie, WI$4K
Sauk Prairie Healthcare INCPrairie Du Sac, WI$2K
Sauk Prairie Healthcare INCPrairie Du Sac, WI$575.92
Sauk Prairie Healthcare INCPrairie Du Sac, WI$280.66

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.